PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About
Organ Systems, Bone Marrow, WHO Classification

Therapy-Related Myeloid Neoplasms

October 10, 2017 peferguson
Immunohistochemistry in Therapy-Related Myeloid Neoplasms

CD34
Usually Positive
CD56
Often Positive
CD7
Variably Positive
 
Cases often will express other myeloid markers.  There is a lot of heterogeneity within this group.

Share this:

  • Share on X (Opens in new window) X
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Share on LinkedIn (Opens in new window) LinkedIn

Related

Post navigation

Previous PostAML with Myelodysplasia-Related ChangesNext PostAcute Myeloid Leukemia, NOS (AML-NOS)

PathMD E-Mail Signup

Poll

What is your most commonly used breast specific IHC marker?
Results

Check-out more in-depth information on these markers the PathMD IHC section of our website/app.

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress